Biotech firm Medtox (MTOX -5.3%) trades lower after its Q3 missed estimates due to reduced order...

|About: Medtox Scientific, Inc. (MTOX)|By:, SA News Editor

Biotech firm Medtox (MTOX -5.3%) trades lower after its Q3 missed estimates due to reduced order flow from its existing customers. EPS came in at $0.15 on sales of $27M, below analysts' expectations for an EPS of $0.17 on revenue of $28.5M.